Cefdinir Dose Adjustment for eGFR 27 mL/min/1.73 m²
For an adult with eGFR of 27 mL/min/1.73 m², reduce cefdinir to 300 mg once daily (or 7 mg/kg once daily for pediatric patients). This represents a 50% reduction from the standard dosing frequency due to significantly impaired renal clearance.
Rationale for Dose Adjustment
With an eGFR of 27 mL/min/1.73 m², this patient has Stage 4 CKD (severe renal impairment), which falls into the category requiring dose adjustment according to FDA labeling 1. The pharmacokinetic data clearly demonstrates that:
- In patients with creatinine clearance <30 mL/min, cefdinir Cmax increases approximately 2-fold
- Half-life increases approximately 5-fold (from ~1.7 hours to ~8.5 hours)
- AUC increases approximately 6-fold 1
These dramatic pharmacokinetic changes occur because cefdinir is predominantly renally eliminated (18.4% of a 300 mg dose recovered unchanged in urine with normal renal function), and renal clearance decreases proportionally with declining creatinine clearance 1.
Specific Dosing Recommendations
For Adults:
- Standard dose with normal renal function: 300 mg twice daily OR 600 mg once daily
- Adjusted dose for eGFR <30 mL/min/1.73 m²: 300 mg once daily 1
For Pediatric Patients (if applicable):
- Standard dose: 14 mg/kg/day divided twice daily (or once daily for certain indications)
- Adjusted dose for CrCl <30 mL/min/1.73 m²: 7 mg/kg once daily (maximum 300 mg) 1
Important Clinical Considerations
Do NOT use the standard twice-daily dosing in this patient, as the 6-fold increase in drug exposure would lead to supratherapeutic levels and increased risk of adverse effects, particularly gastrointestinal toxicity and potential neurotoxicity (as seen with other cephalosporins in renal impairment) 1.
Monitor for drug accumulation if treatment extends beyond 5-7 days, as the prolonged half-life means steady-state will take longer to achieve and drug will persist longer if toxicity develops.
Hemodialysis consideration: If this patient progresses to requiring hemodialysis, further adjustment is needed: 300 mg (or 7 mg/kg) every other day, with an additional dose after each dialysis session, as hemodialysis removes 63% of cefdinir from the body 1.
Estimation of Renal Function
The FDA label provides formulas for estimating creatinine clearance when precise measurement isn't available 1:
For adults:
- Males: CLcr = (weight in kg) × (140 - age) / [(72) × (serum creatinine in mg/dL)]
- Females: CLcr = 0.85 × above value
Since you've provided an eGFR of 27 mL/min/1.73 m², this already indicates severe renal impairment requiring dose adjustment.
Duration of Therapy
The adjusted dose should be maintained for the full treatment duration appropriate for the infection being treated (typically 5-10 days for respiratory tract infections, 10 days for skin infections) 1. The dose reduction affects frequency, not duration of therapy.